Market regulator to review Pacific Edge disclosures

Market regulator to review Pacific Edge disclosures
Chair Chris Gallaher said the company had been “jogging along” but the large capital raise will allow it to sprint. (Photo: screenshot)
Dan Brunskill
Listed market regulator NZ RegCo will review Pacific Edge’s disclosures regarding today’s capital raise, having already engaged with the firm when some details were made public on the ASX.Just two weeks ago, Pacific Edge was attempting to quell rumours after documents it provided to the ASX referred to an A$70 million capital raise managed by Bell Potter Securities, Forsyth Barr and Jarden Securities.Today, the cancer diagnostics firm announced a similar capital raise, managed by the same brokers but targeting $60m with shares...

More Markets

NZ sharemarket up 0.5% ahead of long weekend
Markets Market Close

NZ sharemarket up 0.5% ahead of long weekend

Pacific Edge's share price fell 7.32%.

Tom Raynel 24 Apr 2025
Pacific Edge suffers another setback in US
Markets

Pacific Edge suffers another setback in US

Shares in cancer diagnostics company Pacific Edge are down 2.44% to $0.120 after another setback in the US market.The US District Court for the Middle District of Pennsylvania has determined that it does not have jurisdiction to review a Local Coverage Determination (LCD) that co...

Staff reporters 24 Apr 2025
Listed retailers stand to gain from Trump tariffs:  Forsyth Barr
Retail

Listed retailers stand to gain from Trump tariffs: Forsyth Barr

Forsyth Barr lifted its KMD Brands target price by 10.4% after Trump tariff walkbacks.

Gregor Thompson 24 Apr 2025
NZ sharemarket rises as Trump backs down
Markets Market Close

NZ sharemarket rises as Trump backs down

The S&P/NZX 50 Index closed up 1.01% or 119.78 points.

Tom Raynel 23 Apr 2025